Chevy Chase Trust Holdings, Inc. Organon & Co. Transaction History

Chevy Chase Trust Holdings, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$16.59 - $23.77 $51,163 - $73,306	-3,084 Reduced 2.1%	143,940 $2.5 Million
Q2 2023 Jul 25, 2023	SELL	$19.27 - $24.63 $20,580 - $26,304	-1,068 Reduced 0.72%	147,024 $3.06 Million
Q1 2023 May 17, 2023	BUY	$21.42 - $32.08 $3.17 Million - $4.75 Million	148,092 New	148,092 $3.48 Million
Q4 2022 Feb 09, 2023	SELL	$23.31 - $28.61 $228,391 - $280,320	-9,798 Reduced 6.29%	146,051 $4.08 Million
Q3 2022 Nov 04, 2022	BUY	$23.4 - $34.25 $28,384 - $41,545	1,213 Added 0.78%	155,849 $3.65 Million
Q2 2022 Aug 10, 2022	BUY	$31.66 - $38.9 $18,109 - $22,250	572 Added 0.37%	154,636 $5.22 Million
Q1 2022 Apr 27, 2022	BUY	$30.45 - $39.36 $7,399 - $9,564	243 Added 0.16%	154,064 $5.38 Million
Q4 2021 Jan 31, 2022	SELL	$28.67 - $37.13 $105,190 - $136,229	-3,669 Reduced 2.33%	153,821 $4.68 Million
Q3 2021 Oct 20, 2021	SELL	$28.63 - $35.64 $279,629 - $348,095	-9,767 Reduced 5.84%	157,490 $5.17 Million
Q2 2021 Jul 20, 2021	BUY	$28.45 - $38.0 $4.76 Million - $6.36 Million	167,257 New	167,257 $5.06 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.